CheckMate 436: Primary efficacy and safety analysis of the phase 2 study evaluating nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma Meeting Abstract
| Authors: | Santoro, A.; Moskowitz, A.; Ferrari, S.; Carlo-Stella, C.; Collins, G.; Fanale, M.; Francis, S.; Sacchi, M.; Savage, K. |
| Abstract Title: | CheckMate 436: Primary efficacy and safety analysis of the phase 2 study evaluating nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma |
| Meeting Title: | 61st Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 193 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Apr 25-28 |
| Meeting Location: | Virtual |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-04-01 |
| Start Page: | 150 |
| Language: | English |
| ACCESSION: | WOS:000645412200194 |
| PROVIDER: | wos |
| PUBMED: | 33928641 |
| DOI: | 10.1111/bjh.17492 |
| Notes: | Meeting Abstract: BSH2021-PO-151 -- Source: Wos |
